Brown & Brown Inc stock (US1113201073): Analyst focus as NYSE insurer trades near USD 72

Brown & Brown Inc shares on the New York Stock Exchange traded around USD 71.90 on 05/29/2026, leaving the US insurance broker broadly stable compared with recent sessions, according to Stock Analysis data as of 05/29/2026, which also put the company’s market capitalization at about USD 19.07 billion.Stock Analysis as of 05/29/2026 The company, headquartered in Daytona Beach, Florida, remains part of the United States insurance sector with its primary listing on the NYSE under the ticker BRO.

The latest full set of quarterly figures came with the fourth quarter and full-year 2024 statement, where management reported total quarterly revenues of about USD 1.2 billion, an increase of 15.4% year-on-year, while organic revenue grew 13.8% over the same period, according to a summary of the earnings release.Company investor relations as of 02/2025 This performance keeps the insurer on the radar of Wall Street research desks at the start of June 2026, especially as US-listed insurance brokers continue to benefit from firm pricing in several commercial lines markets.

As of: 01.06.2026

By the editorial team - specialized in equity coverage.

Brown & Brown Inc: core business model

Brown & Brown Inc operates as an insurance broker and risk advisor that connects corporate, public-sector and individual clients with carriers across retail and specialty distribution channels, generating most of its revenue from commissions and fees tied to property and casualty, employee benefits and personal insurance placements.

What banks and research houses say about Brown & Brown Inc

Analyst coverage on Brown & Brown Inc remains active in 2026, with major US brokers highlighting the company’s consistent organic growth profile and its history of bolt-on acquisitions in the fragmented insurance brokerage market, as reflected in consensus summaries from equity research aggregators that classify the stock broadly between neutral and positive ratings.MarketBeat as of 05/30/2026 According to MarketBeat as of 05/30/2026, the consensus across the analysts tracked points to a moderate buy stance, with an average 12-month price target that sits above the late-May 2026 spot price level, underlining expectations for further earnings growth and ongoing execution on acquisitions.

Beyond the headline stance, several US and global investment banks emphasize Brown & Brown’s mix of organic expansion and deal-making, pointing to its demonstrated ability to integrate smaller regional brokers and niche specialty platforms into its broader network and to translate those combinations into higher margins over time.TipRanks as of 05/30/2026 The consensus view also factors in the resilience of insurance brokerage cash flows in different phases of the economic cycle, with Brown & Brown often cited as a beneficiary of steady demand for risk transfer solutions from mid-market US companies and selected international clients.

Conclusion

Brown & Brown Inc enters June 2026 with its NYSE-listed shares trading close to USD 72 and with a market capitalization of around USD 19 billion, underpinned by double-digit organic revenue growth in the fourth quarter of 2024 and a scalable brokerage platform. The analyst consensus compiled by leading data aggregators remains broadly supportive, highlighting the company’s ability to combine organic initiatives with smaller acquisitions in a US-centered insurance market that still offers room for consolidation. For investors tracking the US insurance brokerage space, the stock’s current trading range and the research community’s stance provide context for how the market is assessing Brown & Brown’s growth and earnings trajectory over the coming quarters.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.